Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11292792 Tricyclic CRBN ligands and uses thereof
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
0
Date Filed
July 3, 2019
0
Date of Patent
April 5, 2022
0
Patent Applicant
Kymera Therapeutics
0
Patent Application Number
16502529
0
Patent Citations
US Patent 10125114 Methods to induce targeted protein degradation through bifunctional molecules
US Patent 10336744 1AP E3 ligase directed proteolysis targeting chimeric molecules
US Patent 10874743 IRAK degraders and uses thereof
Patent Citations Received
US Patent 12091411 IRAK degraders and uses thereof
0
US Patent 12077555 STAT degraders and uses thereof
0
Patent Inventor Names
Arthur F. Kluge
0
Yi Zhang
0
Nan Ji
0
Matthew M. Weiss
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
11292792
0
Patent Primary Examiner
Deepak R Rao
0
CPC Code
A61K 31/45
0
C07D 401/04
0
Find more entities like US Patent 11292792 Tricyclic CRBN ligands and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE